ImmunotiX 250 By XYMOGEN EP Overview & Drug Interactions
Check For Interactions With ImmunotiX 250
Supplement: ImmunotiX 250 by XYMOGEN EP
ImmunotiX 250 Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Whole Glucan Particle
| Ingredient Group | Beta-Glucans |
|---|---|
| Category | fiber |
- Beta-Glucan
Drugs that interact with ImmunotiX 250 by XYMOGEN EP
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Capsule(s)
|
| Maximum serving Sizes: |
1 Capsule(s)
|
| Servings per container | 30 |
| UPC/BARCODE | 871149002909 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Whole Glucan Particle |
250 mg
|
Beta-Glucans |
--
|
| Other Ingredients: |
Dicalcium phosphate anhydrous
HPMC
Stearic Acid
Magnesium Stearate
Silica
Medium-Chain Triglycerides
|
|---|
Label Statments:
| Brand IP Statement(s) |
- (C) 2013 XYMOGEN
- ImmunotiX 250(TM) delivers 250 mg of whole glucan particle per capsule, providing beta 1,3/1,6 glucan - a unique complex carbohydrate purified from Saccharomyces cerevisiae (baker's yeast).
- MAY BE COVERED BY ONE OR MORE OF THE FOLLOWING PATENTS AND APPLICATIONS: US 7,981,447; US 7,022,685; US 7,566,704; US 6,369,216; US 5,702,719 and patents pending.
- All XYMOGEN(R) Formulas Meet or Exceed cGMP Quality Standards.
|
|---|---|
| General Statements |
- This package is completely recyclable {recycle}
- Taken orally, ImmunotiX 250 primes and mobilizes the cells that support the body's first-line immune response.
- EXCLUSIVE PATENTED
- PATENTED 1,3/1,6 WHOLE GLUCAN PARTICLE Clinically Tested Worldwide
- PHARMACEUTICAL GRADE PROFESSIONAL USE ONLY
|
| Suggested/Recommended/Usage/Directions |
- DIRECTIONS: For ongoing immune support: Take one capsule daily, first thing in the morning or last thing at night (before or well after a meal), with a full 8 oz glass of water. For fast-acting immune support: Take up to two capsules per day, as above; or use as directed by your healthcare practitioner.
|
| Precautions |
- Consult your healthcare practitioner before use. Do not use if tamper seal is damaged.
- STORAGE: Keep closed in a cool, dry place out of reach of children.
|
| Formula |
- It is natural, non-genetically modified (non-GMO), hypoallergenic, patented, and generally recognized as safe (GRAS).
|
| FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
| Storage |
- STORAGE: Keep closed in a cool, dry place out of reach of children.
|
| Formulation |
- DOES NOT CONTAIN: Wheat, gluten, corn, yeast protein, soy, animal or dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically-modified organisms (GMOs), artificial colors, artificial sweeteners, or preservatives.
|
| FDA Statement of Identity |
- Dietary Supplement
|
| Seals/Symbols |
- Vegetable CAPSULES
|
| General |
- ZLB-IMMUN250-01 REV. 060313
|
Brand Information
See all products by this brand
| Manufacturer | |
|---|---|
| Name | XYMOGEN Exclusive Professional Formulas |
| Street Address | 6900 Kingspointe Pkwy. |
| City | Orlando |
| State | FL |
| ZipCode | 32819 |
| Phone Number | 800-647-6100 |
| Web Address | www.xymogen.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.